Biological Characterization and Development Workflows for Targeted Protein Degradation
This webinar will focus on PROTAC biology workflows, such as in vitro screening assays, in vivo testing, and optimization of DMPK properties. Topics will include the best use of biochemical assays to measure binary/ternary complex formation, cell-based assays to assess target engagement and degradation, strategies for enhancing drug delivery and formulation, and PK/PD evaluation of PROTACs in animal models.
Key Learning Objectives:
- PROTAC biology workflows, including in vitro screening assays, in vivo testing, and optimization of DMPK properties
- Strategies for enhancing drug delivery and formulation
- PK/PD evaluation of PROTACs in animal models
Related Content
Strategies for Novel Autoimmune Drug Development: Preclinical Efficacy and Case Studies of JAK-STAT Targeted Therapies JAK Family Molecules: Central Hubs...
VIEW RESOURCEAccelerating SLE Drug Discovery: A Short-Term BM12-Induced Mouse Model for Efficient Drug Screening Systemic lupus erythematosus (SLE) is a chronic...
VIEW RESOURCE
